Skip to main navigation
BioCryst Pharmaceuticals, Inc. Logo
  • Home
  • News & Events
    Press Releases Events & Presentations
  • Stock
    Stock Quote & Chart Historic Stock Lookup Analyst Coverage
  • Corporate Governance
    Board of Directors Committee Composition Code of Conduct & Compliance Committee Charters Corporate Responsibility
  • Finance & Filings
    Financial Profile SEC Documents Proxy Online Quarterly Results
  • Investor Resources
    Investor FAQ Email Alerts RSS News Feeds

SEC Filing Details

Document Details

Form
8-K
Filing Date
Jul 11, 2023
Document Date
Jul 7, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

Contact Investor Relations

investorrelations@biocryst.com
+1 919.859.7910

Investor Tools

  • Print Page
  • Printed Materials
  • Email Alerts
  • RSS News Feeds
  • Share Page
  • © BioCryst Pharmaceuticals, Inc. All Rights Reserved. 2023
  • Facebook
  • Twitter
  • LinkedIn
  • RSS